On September 2, 2016, New Jersey Superior Court Judge Nelson Johnson issued an Order and Opinion barring Plaintiffs’ experts in the ongoing litigation involving claims against Johnson & Johnson, alleging ovarian cancer caused by the drug maker’s talc products. For those that follow Mass Tort litigation in New Jersey, that decision was significant, but not… Continue Reading
Can we help? Call us today at (609) 791-7009 or fill out the contact form below. Any information you provide is considered confidential and will not be shared outside of our firm.
Subscribe to this blog by email
Martin P. Schrama is Chairman and Co-Founder of the Stark & Stark Mass Tort Litigation Group. Mr. Schrama has extensive experience prosecuting mass and class actions on both the trial and appellate levels of the federal and state courts of New Jersey and New York, as well as numerous other jurisdictions throughout the nation. Mr. Schrama is also supervisory counsel for numerous Stark & Stark Litigation Teams. Click here to read other blog posts by Martin P. Schrama.
Stefanie Colella-Walsh is a Shareholder and member of the Stark & Stark Mass Tort Litigation Group, where she concentrates her practice in complex litigation with a focus in mass tort and pharmaceutical litigation. Ms. Colella-Walsh is also a Shareholder in several of Stark & Stark’s Litigation Teams and has extensive experience as a trial attorney. Click here to read other blog posts by Stefanie Colella-Walsh.
Kevin M. Hart is Co-Founder of the Stark & Stark Mass Tort Litigation Group. Mr. Hart has over 30 years of experience as a trial attorney stemming from his work as a Deputy Attorney General with the State of New Jersey, Division of Criminal Justice, to his development and management of several practice groups at Stark & Stark. Mr. Hart has been certified by the Supreme Court of New Jersey as a Certified Civil Trial Attorney since 1994. Click here to read other blog posts by Kevin M. Hart